Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.

ABSTRACT: IRE1α-XBP1 signaling is emerging as a central orchestrator of malignant progression and immunosuppression in various cancer types. Employing a computational XBP1s detection method applied to TCGA datasets, we demonstrate that expression of the XBP1s mRNA isoform predicts poor survival in non-small cell lung cancer (NSCLC) patients. Ablation of IRE1α in malignant cells delays tumor progression and extends survival in mouse models of NSCLC. This protective effect is accompanied by alterations in intratumoral immune cell subsets eliciting durable adaptive anti-cancer immunity. Mechanistically, cancer cell-intrinsic IRE1α activation sustains mPGES-1 expression, enabling production of the immunosuppressive lipid mediator prostaglandin E₂. Accordingly, restoring mPGES-1 expression in

SUBMITTER: Crowley MJP 

PROVIDER: S-EPMC9829901 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature